Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income	$ 183,526	$ 158,701	$ 219,273
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	6,941	7,218	16,334
Non-cash stock-based expense	10,111	7,848	14,799
(Loss) gain on extinguishment of debt	549	(412)	8,349
Gain on sale of assets	0	0	(724)
Deferred income taxes	5,932	15,226	14,464
Distributions from investments	0	0	134
Equity in (earnings) losses from investments	(1,262)	4,995	(2,675)
Net (gains) losses on investment securities	(2,594)	7,980	(9,648)
Equity in (earnings) losses from real estate ventures	(2,202)	5,946	(9,972)
Distributions from real estate ventures	4,248	3,429	25,326
Non-cash interest expense	2,225	4,114	4,838
Non-cash lease expense	3,410	3,381	21,941
Provision for credit losses	0	0	3,331
Other	18	376	393
Changes in assets and liabilities:
Receivables	13,825	(24,804)	(9,630)
Inventories	489	2,168	2,930
Accounts payable and accrued liabilities	(5,358)	(8,318)	196
Payments due under the Master Settlement Agreement	(8,395)	844	(31,590)
Investments in real estate, net	0	0	5,652
Litigation accruals	(2,177)	(5,185)	(1,637)
Other assets and liabilities, net	698	(2,190)	(16,865)
Net cash provided by operating activities	209,984	181,317	255,219
Cash flows from investing activities:
Sale of investment securities	34,705	23,929	45,627
Maturities of investment securities	89,681	53,030	71,505
Purchase of investment securities	(115,225)	(54,040)	(124,080)
Proceeds from sale or liquidation of long-term investments	5,530	9,266	11,509
Purchase of long-term investments	(9,416)	(4,363)	(14,316)
(Increase) decrease in restricted assets	(18)	5	(5)
Investments in real estate ventures	(17,433)	(25,569)	(49,463)
Distributions from investments in real estate ventures	9,186	4,946	11,936
Proceeds from sale of fixed assets	3	0	17
Capital expenditures	(10,557)	(9,957)	(13,506)
Increase in cash surrender value of life insurance policies	(1,169)	(1,173)	(1,219)
Purchase of subsidiaries	0	0	(500)
Pay downs of investment securities	113	198	525
Net cash used in investing activities	(14,600)	(3,728)	(61,970)
Cash flows from financing activities:
Proceeds from issuance of debt	0	0	875,000
Repayments of debt	(23,679)	(12,253)	(862,973)
Deferred financing costs	0	0	(20,109)
Borrowings under revolver	87,576	112,558	27,892
Repayments on revolver	(109,611)	(90,547)	(27,868)
Dividends and distributions on common stock	(126,232)	(128,262)	(131,798)
Contributions from non-controlling interest	0	0	1,625
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting and exercise of stock options	(3,706)	(2,622)	(13,145)
Cash transferred to Douglas Elliman Inc. at the Distribution	0	0	(212,571)
Other	0	(938)	(130)
Net cash used in financing activities	(175,652)	(122,064)	(364,077)
Net increase (decrease) in cash, cash equivalents and restricted cash	19,732	55,525	(170,828)
Cash, cash equivalents and restricted cash, beginning of year	250,374	194,849	365,677
Cash, cash equivalents and restricted cash, end of year	$ 270,106	$ 250,374	$ 194,849